Topiramate therapy in patients with refractory epilepsy;Tratamiento con topiramato en pacientes con epilepsia refractaria

Revista de Neurologia

Volumn 37, Issue 5, 2003, Pages 401-404

  Corredera Garcia E ^a   Gomez Alonso J ^b   Arias, M ^c   Seijo Martinez M ^d   Rodriguez J ^d   Rubio Nazabal, E ^e   Lopez F ^f  

^a HOSPITAL DO MEIXOEIRO   (Spain)

^b HOSPITAL XERAL CÍES   (Spain)

^c Department of Pneumology   (Spain)

^d Department of Neurology   (Spain)

^e HOSPITAL JUAN CANALEJO   (Spain)

^f Universidad de La Coruña   (Spain)

Author keywords

Effectiveness; Refractory epilepsy Safety; Seizure free; Topiramate

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ADULT; AGED; ANTICONVULSANT THERAPY; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; EPILEPSY; FEMALE; HUMAN; IDIOPATHIC DISEASE; MALE; SEIZURE; SIDE EFFECT; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0242391236     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3705.2003135     Document Type: Article

References (21)

1. Shorvon SD. The epidemiology and treatment of chronic and refractory epilepsy. Epilepsia 1996; 37 (Suppl 2): S1-3.
2. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000; 342: 314-9.
3. Schneiderman JH. Monotherapy versus polytherapy in epilepsy: a framework for patient management. Can J Neurol Sci 1998; 25 (Suppl 4): S9-13.
4. Stephen LJ, Sills GJ, Brodie MJ. Topiramate in refractory epilepsy: a prospective observational study. Epilepsia 2000; 41: 977-80.
5. Gatti G, Bonomi I, Jannuzzi G, Perucca E. The new antiepileptic drugs: pharmacological and clinical aspects. Curr Pharm Des 2000; 6: 839-60.
6. Privitera MD, Brodie MJ, Neto W, Wang S. Topiramate, carbamazepine, and valproate in the spectrum of newly diagnosed epilepsy. Neurology 2001; 56 (Suppl 3): 332.
7. Arroyo S, Squires L, Wang S, Twyman R. Topiramate: effective as monotherapy in dose-response study in newly diagnosed epilepsy. Epilepsia 2002; 43 (Suppl 7): 241.
8. Shank RP, Gardocki JF, Streeter AJ, Maryanoff BE. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia 2000; 41 (Suppl 1): S3-9.
9. Jette N, Guberman A, Marson AG, Kadir ZA, Hutton JL. The efficacy and tolerability of topiramate in drug resistant partial epilepsy - a Cochrane metaanalysis. Can J Neurol Sci 2000; 27 (Suppl 2): S48.
10. Abou-Khalil B, Bazil C, Bruni J. Topiramate in the long-term management of refractory epilepsy. Epilepsia 2000; 41 (Suppl I): S72-6.
11. Herranz JL. Topiramato: antiepiléptico de amplio espectro, administrado a 224 pacientes con epilepsias rebeldes. Rev Neurol 2000; 31: 822-8.
12. Korean Topiramate Study Group. Low dose and slow titration of topiramate as adjunctive therapy in refractory partial epilepsies: a multicentre open clinical trial Seizure 2002; 11: 255-60.
13. Ben-Menachem E, Henriksen O, Dam M, Mikkelsen M, Schmidt D, Reid S, et al. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia 1996; 37: 539-43.
14. Privitera M, Fincham R, Penry J, Reife R, Kramer L, Pledger G, et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group. Neurology 1996; 46: 1678-83.
15. Faught E, Wilder BJ, Ramsay RE, Reife RA, Kramer LD, Pledger GW, et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group. Neurology 1996; 46: 1684-90.
16. Tassinari CA, Michelucci R, Chauvel P, Chodkiewicz J, Shorvon S, Henriksen O, et al. Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Epilepsia 1996; 37: 763-8.
17. Sharief M, Viteri C, Ben-Menachem E, Weber M, Reife R, Pledger G, et al. Double-blind, placebo controlled study of topiramate in patients with refractory partial epilepsy. Epilepsy Res 1996; 25: 217-24.
18. Pledger G, Reife RA, Lim P. Overview of topiramate efficacy from adjunctive therapy trials. Epilepsia 1995; 36 (Suppl 3): S150.
19. Elterman R, Glauser TA, Wyllie E, Reife R, Wu SC, Pledger G, et al. A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Neurology 1999; 52: 1338-44.
20. Biton V, Montouris GD, Ritter F, Riviello JJ, Reife R, Lim P. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Neurology 1999; 52: 1330-7.
21. Marson AG, Kadir ZA, Chadwick DW. New antiepileptic drugs: a systematic review of their efficacy and tolerability. BMJ 1996; 313: 1169-74.